acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Nov 2022 Invitation to presentation of Acarix´s third quarter report 2022 Acarix will publish its third quarter results on Wednesday 16 November 2022 at 08.00 am (CEST). A live webcast will be held at 16.30 (C... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 28 Sep 2022 Patient enrollment completed in the FILTER-SCAD randomized controlled multi-center trial The FILTER-SCAD study is a randomized controlled clinical trial including more than 2,000 patients with suspected coronary artery disea... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 26 Sep 2022 Acarix and the American College of Cardiology announce strategic collaboration The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to deve... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Sep 2022 Acarix presents at the Redeye event, Theme: Diagnostics On September 27 at 11.30 am CEST, Helen Ljungdahl Round, President and CEO at Acarix will present the company´s latest developmen... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report November 18, 2024 25 Aug 2022 Acarix AB (publ) publishes Interim Report, January – June 2022 Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Aug 2022 Invitation to presentation of Acarix´s second quarter report Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES... Continue reading
acarix Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory November 18, 2024 22 Jun 2022 Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Press release Malmö, Sweden, June 22, 2022 Acarix partners with Strategic Health AK to roll-out CADScor®Syst... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 10 Jun 2022 Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana. Press release Malmö, Sweden, June 10, 2022 Acarix signs additional commercial agreement in US and receives order... Continue reading
acarix Corporate Information, English, IR, News, Order, Sales November 18, 2024 03 Jun 2022 Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee Press release Malmö, Sweden, June 3, 2022 Acarix signs additional commercial agreement in US and receives rapid... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 11 May 2022 Announcement from Acarix’s annual general meeting Press release Malmö, Sweden, May 11, 2022 Announcement from Acarix's annual general meeting The annual general ... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report November 18, 2024 11 May 2022 Acarix AB (publ) publishes Interim Report, January – March 2022 Press release Malmö, Sweden, May 11, 2022 Acarix AB (publ) publishes Interim Report, January – March 2022 ... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 06 May 2022 Acarix presents at Naventus Health Care Summit 2022 Press release Malmö, Sweden, May 6, 2022 Acarix presents at Naventus Health Care Summit 2022 Helen Ljungdahl Ro... Continue reading